Trial Profile
Impact of Exercise on Lung Function in Patients With Chronic Obstructive Pulmonary Disease
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 25 Aug 2020
Price :
$35
*
At a glance
- Drugs Budesonide/formoterol (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 18 Jun 2018 Status changed from not yet recruiting to recruiting.
- 14 Jun 2018 New trial record